Belpointe Asset Management LLC Pfizer Inc Transaction History

Belpointe Asset Management LLC

$1.28 Billion
Q2 2024

A detailed history of Belpointe Asset Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Belpointe Asset Management LLC holds 239,709 shares of PFE stock, worth $6.58 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

239,709

Previous 193,253 24.04%

Holding current value

$6.58 Million

Previous $5.36 Million 25.08%

% of portfolio

0.52%

Previous 0.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$25.26 - $29.6 $1.17 Million - $1.38 Million	46,456 Added 24.04%	239,709 $6.71 Million
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $2.28 Million - $2.62 Million	88,008 Added 83.62%	193,253 $5.36 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $483,587 - $628,127	18,507 Added 21.34%	105,245 $3.03 Million
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $21,500 - $25,131	670 Added 0.78%	86,738 $2.88 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $1.65 Million - $1.91 Million	-45,748 Reduced 34.71%	86,068 $3.16 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $281,796 - $366,857	7,154 Added 5.74%	131,816 $5.38 Million
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $711,378 - $928,625	17,039 Added 15.83%	124,662 $6.39 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $652,986 - $797,133	14,922 Added 16.1%	107,623 $4.71 Million
Q2 2022 Aug 02, 2022	SELL	$46.53 - $55.17 $1.21 Million - $1.43 Million	-25,921 Reduced 21.85%	92,701 $4.86 Million
Q1 2022 Apr 28, 2022	SELL	$45.75 - $56.69 $404,979 - $501,819	-8,852 Reduced 6.94%	118,622 $6.14 Million
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $549,142 - $814,012	13,290 Added 11.64%	127,474 $7.53 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $1.07 Million - $1.38 Million	-27,304 Reduced 19.3%	114,184 $4.91 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $120,118 - $136,074	3,345 Added 2.42%	141,488 $5.54 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $2.01 Million - $2.27 Million	-60,077 Reduced 30.31%	138,143 $5 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $2.15 Million - $2.74 Million	64,369 Added 48.09%	198,220 $7.3 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $161,290 - $189,230	-5,080 Reduced 4.66%	103,987 $3.39 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $948,182 - $1.11 Million	29,864 Added 28.72%	133,851 $4.91 Million
Q2 2020 Jul 20, 2020	BUY	$30.12 - $36.54 $153,009 - $185,623	5,080 Added 4.89%	109,067 $3.57 Million
Q1 2020 Jul 20, 2020	SELL	$27.03 - $38.62 $26,002 - $37,152	-962 Reduced 0.92%	103,987 $3.39 Million
Q4 2019 Feb 18, 2020	BUY	$32.92 - $37.36 $658,465 - $747,274	20,002 Added 23.55%	104,949 $4.11 Million
Q3 2019 Jan 16, 2020	SELL	$32.49 - $42.13 $285,976 - $370,828	-8,802 Reduced 9.39%	84,947 $3.05 Million
Q2 2019 Nov 22, 2019	SELL	$36.98 - $41.52 $109,054 - $122,442	-2,949 Reduced 3.05%	93,749 $0
Q1 2019 Jun 11, 2019	BUY	$37.5 - $41.2 $155,775 - $171,144	4,154 Added 4.49%	96,698 $4.11 Million
Q4 2018 Mar 06, 2019	BUY	$38.47 - $43.86 $94,867 - $108,158	2,466 Added 2.74%	92,544 $4.04 Million
Q3 2018 Nov 23, 2018	BUY	$34.47 - $41.81 $223,744 - $271,388	6,491 Added 7.77%	90,078 $3.97 Million
Q2 2018 Aug 06, 2018	SELL	$32.98 - $35.16 $9,564 - $10,196	-290 Reduced 0.35%	83,587 $3.03 Million
Q1 2018 Aug 06, 2018	SELL	$31.91 - $37.02 $149,466 - $173,401	-4,684 Reduced 5.29%	83,877 $2.98 Million
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $110,190 - $116,915	3,313 Added 3.89%	88,561 $3.21 Million
Q3 2017 Nov 16, 2017	BUY	$31.0 - $34.15 $2.64 Million - $2.91 Million	85,248	85,248 $3.04 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Account

Belpointe Asset Management LLC Pfizer Inc Transaction History